In the following video, Motley Fool health-care analyst David Williamson takes a question from a Fool reader, who asks, "Should I buy, sell or hold Teva Pharmaceutical Industries Limited (TEVA 1.03%)?"
Ask a Fool: Buy, Sell or Hold Teva?
By Dave Williamson – Jun 27, 2013 at 5:43PM EST
NYSE: TEVA
Teva Pharmaceutical Industries
Market Cap
$37B
Today's Change
(-1.03%) $0.33
Current Price
$31.56
Price as of December 29, 2025 at 4:00 PM ET
Is Teva too dangerous to buy right now?
Read Next
About the Author
The Motley Fool's Healthcare Analyst, I specialize in Pharma, Biotech, and how the ACA (Obamacare) is changing the business of healthcare in America. Follow me on Twitter for breaking stock news, policy thoughts, and misc musings...
Stocks Mentioned
Teva Pharmaceutical Industries
NYSE: TEVA
$31.56 (0.01%) $0.33
Biogen
NASDAQ: BIIB
$176.83 (0.00%) $0.25
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Advertisement